Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Precision Biosciences (DTIL) Net Margin (2018 - 2025)

Precision Biosciences (DTIL) has disclosed Net Margin for 8 consecutive years, with 37.81% as the latest value for Q4 2025.

  • Quarterly Net Margin rose 375944.0% to 37.81% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 143.97% through Dec 2025, down 11314.0% year-over-year, with the annual reading at 2.58% for FY2025, N/A changed from the prior year.
  • Net Margin for Q4 2025 was 37.81% at Precision Biosciences, up from 153861.54% in the prior quarter.
  • The five-year high for Net Margin was 50.96% in Q2 2024, with the low at 153861.54% in Q3 2025.
  • Average Net Margin over 5 years is 17688.31%, with a median of 113.21% recorded in 2021.
  • Peak annual rise in Net Margin hit 375944bps in 2025, while the deepest fall reached -15042959bps in 2025.
  • Over 5 years, Net Margin stood at 484.52% in 2021, then surged by 82bps to 85.5% in 2022, then skyrocketed by 53bps to 40.57% in 2023, then crashed by -9074bps to 3721.63% in 2024, then soared by 101bps to 37.81% in 2025.
  • According to Business Quant data, Net Margin over the past three periods came in at 37.81%, 153861.54%, and 117327.78% for Q4 2025, Q3 2025, and Q2 2025 respectively.